mGluR8 (Metabotropic Glutamate Receptor 8), encoded by the GRM8 gene (also known as GRM8 or mGlu8), is a member of the Group III metabotropic glutamate receptor family. Among Group III receptors, mGluR8 has the highest glutamate affinity (EC50 ~10-30 μM), positioning it as a sensitive detector of ambient glutamate levels that provides fine-tuned negative feedback at excitatory synapses. mGluR8 is predominantly expressed in the olfactory bulb, cerebral cortex, hippocampus, and amygdala, where it regulates synaptic transmission, plasticity, and various behavioral processes [1].
The receptor has attracted significant interest as a therapeutic target for neurological and psychiatric disorders. mGluR8 activation has shown anxiolytic and anticonvulsant properties, while modulation of the receptor may offer benefits in depression, drug addiction, and cognitive disorders. The receptor's strategic position as a presynaptic inhibitory autoreceptor makes it particularly suitable for therapies aimed at reducing excessive excitatory transmission without completely blocking synaptic communication.
The GRM8 gene (Gene ID: 2918) is located on chromosome 7q31.3-q32.1 in humans. The gene spans approximately 40 kb and contains 9 exons. Alternative splicing produces multiple mRNA isoforms with distinct expression patterns and functional properties. The GRM8 promoter contains regulatory elements for brain region-specific expression and activity-dependent regulation.
Key features:
mGluR8 shares the class C GPCR architecture:
| Domain | Description |
|---|---|
| N-terminal VFT domain | Large extracellular domain (~400 aa) with high glutamate affinity |
| Cysteine-rich domain | Flexible linker with structural disulfide bonds |
| 7 Transmembrane domain | Classic seven-helix bundle |
| C-terminal tail | Intracellular domain with interaction motifs |
Among Group III mGluRs, mGluR8 has the highest glutamate affinity, requiring only moderate glutamate concentrations for activation. This property allows mGluR8 to respond to lower levels of synaptic activity compared to mGluR4 and mGluR7.
mGluR8 functions as a homodimer on the cell surface. The dimer interface involves both the VFT and transmembrane domains, similar to other class C GPCRs.
mGluR8 serves as a sensitive inhibitory autoreceptor: [2]
This allows mGluR8 to provide continuous negative feedback that maintains synaptic homeostasis.
| Region | Expression Level | Primary Function |
|---|---|---|
| Olfactory bulb | Very high | Olfactory signal processing |
| Cortex (Layer II/III) | High | Corticocortical modulation |
| Hippocampus | High | Synaptic plasticity |
| Amygdala | High | Emotional processing |
| Thalamus | Moderate | Sensory relay |
| Cerebellum | Low-moderate | Motor learning |
mGluR8 is highly expressed in the olfactory bulb: [3]
mGluR8 modulates various forms of plasticity: [4]
mGluR8 is implicated in anxiety pathophysiology: [5]
mGluR8 is a key regulator of seizure activity: [6]
mGluR8 involvement in mood disorders:
mGluR8 modulation in ischemia: [7]
mGluR8 in addiction pathophysiology: [8]
| Compound | Mechanism | Status | Application |
|---|---|---|---|
| L-AP4 | Group III agonist | Research | Experimental |
| DCPBG | mGluR8 agonist | Research | Anxiety |
| LY-382,884 | mGluR8 antagonist | Research | Experimental |
mGluR8 PAMs are being developed: [9]
| Compound | Selectivity | Development |
|---|---|---|
| AZD8797 | mGluR8 PAM | Research |
| JNJ-55511118 | mGluR8 PAM | Preclinical |
mGluR8 couples to Gi/o proteins:
| Pathway | Effect | Cellular Outcome |
|---|---|---|
| cAMP/PKA | Inhibited | Reduced transmitter release |
| Ca²⁺ channels | Inhibited | Decreased exocytosis |
| K⁺ channels | Activated | Hyperpolarization |
| ERK/MAPK | Variable | Context-dependent |